Literature DB >> 7671321

Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts.

H Sakuta1, K Inaba, S Muramatsu.   

Abstract

The effect of calcitonin gene-related peptide (CGRP) was investigated on cytokine-induced IL-9 production by Swiss 3T3 fibroblasts. CGRP by itself had little effect on IL-6 production, and substantially enhanced that induced by IL-1 beta or TNF alpha at concentrations of 10(-8) M or higher. The action of CGRP was mediated by a CGRP-specific receptor. In contrast, calcitonin had no effect at all. A kinetic study of IL-6 activity in the culture supernatant showed that CGRP not only accelerated but also increased IL-6 production. Enhancement by CGRP of cytokine-dependent IL-6 production was ascribed to the increased accumulation of IL-6 mRNA. IL-1 beta-induced IL-6 production was maintained by CGRP after removal of IL1 beta. The addition of CGRP to the culture following stimulation with IL-1 beta or IL-1 beta plus CGRP decelerated the decay of IL-6 mRNA. These results indicate that the augmenting effect of CGRP is mediated, at least in part, by the stabilization of IL-6-specific mRNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671321     DOI: 10.1006/cimm.1995.1182

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Association of Serum Levels of Calcitonin Gene-related Peptide and Cytokines during Migraine Attacks.

Authors:  Dawei Han
Journal:  Ann Indian Acad Neurol       Date:  2019 Jul-Sep       Impact factor: 1.383

2.  Can COVID-19 vaccines relieve severe tension-type headache and migraine?

Authors:  Jordi González-Menacho; Mónica Villas-Roca; Helena Castañé; Jorge Joven; Jordi Camps; Simona Iftimie
Journal:  Med Hypotheses       Date:  2022-02-22       Impact factor: 1.538

3.  Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis.

Authors:  Matthias Ebbinghaus; Gisela Segond von Banchet; Julia Massier; Mieczyslaw Gajda; Rolf Bräuer; Michaela Kress; Hans-Georg Schaible
Journal:  Arthritis Res Ther       Date:  2015-11-21       Impact factor: 5.156

4.  Could CGRP Antagonists Be Helpful in the Fight Against COVID-19?

Authors:  Carrie E Robertson
Journal:  Headache       Date:  2020-06-15       Impact factor: 5.311

5.  COVID-19 pneumonia during long-term migraine prophylaxis with fremanezumab: a case report.

Authors:  Luigi Francesco Iannone; Pierangelo Geppetti; Alberto Chiarugi; Francesco De Cesaris
Journal:  Intern Emerg Med       Date:  2021-06-12       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.